Berikutnya

Putar otomatis

Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

1 Tampilan • 08/09/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis